Browse by Academic Unit (A-Z)
Up a level- White Rose Consortium (129594)
- The University of Leeds (55456)
- Faculty of Medicine and Health (Leeds) (12377)
- Institute of Molecular Medicine (LIMM) (Leeds) (1118)
- Section of Oncology and Clinical Research (Leeds) (75)
- National Institute for Health Research (Leeds) (4)
- NCRN (NIHR Cancer Research Network) (Leeds) (3)
- National Institute for Health Research (Leeds) (4)
- Section of Oncology and Clinical Research (Leeds) (75)
- Medicine & Health Faculty Office (Leeds) (92)
- National Institute for Health Research (Leeds) (4)
- NCRN (NIHR Cancer Research Network) (Leeds) (3)
- National Institute for Health Research (Leeds) (4)
- Institute of Molecular Medicine (LIMM) (Leeds) (1118)
- Faculty of Medicine and Health (Leeds) (12377)
- The University of Leeds (55456)
Article
Cameron, DA, Anderson, A, Toy, E et al. (9 more authors) (2002) Block sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer? British Journal of Cancer, 87 (12). pp. 1365-1369. ISSN 0007-0920
Coleman, RE, Winter, MC, Cameron, D et al. (11 more authors) (2010) The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer. British Journal of Cancer, 102 (7). 1099 - 1105. ISSN 0007-0920
Morris, E, Haward, RA, Gilthorpe, MS et al. (2 more authors) (2006) The impact of the Calman–Hine report on the processes and outcomes of care for Yorkshire's colorectal cancer patients. British Journal of Cancer, 95 (8). pp. 979-985. ISSN 0007-0920